Cargando…
In Silico Models for Anti-COVID-19 Drug Discovery: A Systematic Review
The coronavirus disease 2019 (COVID-19) is a severe worldwide pandemic. Due to the emergence of various SARS-CoV-2 variants and the presence of only one Food and Drug Administration (FDA) approved anti-COVID-19 drug (remdesivir), the disease remains a mindboggling global public health problem. Devel...
Autor principal: | Onyango, Okello Harrison |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287514/ https://www.ncbi.nlm.nih.gov/pubmed/37362912 http://dx.doi.org/10.1155/2023/4562974 |
Ejemplares similares
-
In-silico analysis of potent Mosquirix vaccine adjuvant leads
por: Onyango, Okello Harrison, et al.
Publicado: (2023) -
In Silico Discovery of Candidate Drugs against Covid-19
por: Cava, Claudia, et al.
Publicado: (2020) -
In Silico Strategies in Tuberculosis Drug Discovery
por: Macalino, Stephani Joy Y., et al.
Publicado: (2020) -
Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics
por: Gupta, Yash, et al.
Publicado: (2023) -
Brazilian essential oils as source for the discovery of new anti-COVID-19 drug: a review guided by in silico study
por: Amparo, Tatiane Roquete, et al.
Publicado: (2021)